Topotecan Plus Sargramostim in Treating Patients With Advanced Cancer

NCT00002950 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL: sargramostim
DRUG: topotecan hydrochloride

Sponsor

Yale University

Collaborators

[object Object]